196 related articles for article (PubMed ID: 36111431)
1. The pathogenesis of organ fibrosis: Focus on necroptosis.
Hao M; Han X; Yao Z; Zhang H; Zhao M; Peng M; Wang K; Shan Q; Sang X; Wu X; Wang L; Lv Q; Yang Q; Bao Y; Kuang H; Zhang H; Cao G
Br J Pharmacol; 2023 Nov; 180(22):2862-2879. PubMed ID: 36111431
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic targets of fibrosis: Translational advances and current challenges.
De Blasio MJ; Ohlstein EH; Ritchie RH
Br J Pharmacol; 2023 Nov; 180(22):2839-2845. PubMed ID: 37846458
[TBL] [Abstract][Full Text] [Related]
3. Targeting cluster of differentiation 26 / dipeptidyl peptidase 4 (CD26/DPP4) in organ fibrosis.
Ohm B; Moneke I; Jungraithmayr W
Br J Pharmacol; 2023 Nov; 180(22):2846-2861. PubMed ID: 36196001
[TBL] [Abstract][Full Text] [Related]
4. Chronic liver diseases: From development to novel pharmacological therapies: IUPHAR Review 37.
Borrello MT; Mann D
Br J Pharmacol; 2023 Nov; 180(22):2880-2897. PubMed ID: 35393658
[TBL] [Abstract][Full Text] [Related]
5. Loss of MLKL ameliorates liver fibrosis by inhibiting hepatocyte necroptosis and hepatic stellate cell activation.
Guo R; Jia X; Ding Z; Wang G; Jiang M; Li B; Chen S; Xia B; Zhang Q; Liu J; Zheng R; Gao Z; Xie X
Theranostics; 2022; 12(11):5220-5236. PubMed ID: 35836819
[No Abstract] [Full Text] [Related]
6. The extracellular matrix as a key regulator of intracellular signalling networks.
Hastings JF; Skhinas JN; Fey D; Croucher DR; Cox TR
Br J Pharmacol; 2019 Jan; 176(1):82-92. PubMed ID: 29510460
[TBL] [Abstract][Full Text] [Related]
7. Translating the matrix.
Whiteford JR; Arokiasamy S; De Rossi G
Br J Pharmacol; 2019 Jan; 176(1):3-4. PubMed ID: 30525194
[TBL] [Abstract][Full Text] [Related]
8. Preclinical rodent models of cardiac fibrosis.
Wang Y; Wang M; Samuel CS; Widdop RE
Br J Pharmacol; 2022 Mar; 179(5):882-899. PubMed ID: 33973236
[TBL] [Abstract][Full Text] [Related]
9. Generation of a multi-functional, target organ-specific, anti-fibrotic molecule by molecular engineering of the extracellular matrix protein, decorin.
Järvinen TAH; Ruoslahti E
Br J Pharmacol; 2019 Jan; 176(1):16-25. PubMed ID: 29847688
[TBL] [Abstract][Full Text] [Related]
10. Programmed Cell Death in Liver Fibrosis.
Gao R; Tang H; Mao J
J Inflamm Res; 2023; 16():3897-3910. PubMed ID: 37674533
[TBL] [Abstract][Full Text] [Related]
11. Regulated Necrosis in Pulmonary Disease. A Focus on Necroptosis and Ferroptosis.
Minagawa S; Yoshida M; Araya J; Hara H; Imai H; Kuwano K
Am J Respir Cell Mol Biol; 2020 May; 62(5):554-562. PubMed ID: 32017592
[TBL] [Abstract][Full Text] [Related]
12. Current challenges in the treatment of cardiac fibrosis: Recent insights into the sex-specific differences of glucose-lowering therapies on the diabetic heart: IUPHAR Review 33.
Sharma A; De Blasio M; Ritchie R
Br J Pharmacol; 2023 Nov; 180(22):2916-2933. PubMed ID: 35174479
[TBL] [Abstract][Full Text] [Related]
13. Targeting Endothelial Necroptosis Disrupts Profibrotic Endothelial-Hepatic Stellate Cells Crosstalk to Alleviate Liver Fibrosis in Nonalcoholic Steatohepatitis.
Yan M; Li H; Xu S; Wu J; Li J; Xiao C; Mo C; Ding BS
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511074
[TBL] [Abstract][Full Text] [Related]
14. Programmed necrosis in cardiomyocytes: mitochondria, death receptors and beyond.
Zhang J; Liu D; Zhang M; Zhang Y
Br J Pharmacol; 2019 Nov; 176(22):4319-4339. PubMed ID: 29774530
[TBL] [Abstract][Full Text] [Related]
15. Opioid research in the time of the opioid crisis.
Traynor JR; Moron JA
Br J Pharmacol; 2023 Apr; 180(7):793-796. PubMed ID: 36813266
[TBL] [Abstract][Full Text] [Related]
16. Mineralocorticoid receptors in non-alcoholic fatty liver disease.
Schreier B; Zipprich A; Uhlenhaut H; Gekle M
Br J Pharmacol; 2022 Jul; 179(13):3165-3177. PubMed ID: 34935140
[TBL] [Abstract][Full Text] [Related]
17. Programmed cell death in hepatic fibrosis: current and perspectives.
Lu JL; Yu CX; Song LJ
Cell Death Discov; 2023 Dec; 9(1):449. PubMed ID: 38086792
[TBL] [Abstract][Full Text] [Related]
18. A Glimpse of necroptosis and diseases.
Yang M; Chen W; He L; Liu D; Zhao L; Wang X
Biomed Pharmacother; 2022 Dec; 156():113925. PubMed ID: 36411617
[TBL] [Abstract][Full Text] [Related]
19. The emerging roles of ferroptosis in organ fibrosis and its potential therapeutic effect.
Huang X; Song Y; Wei L; Guo J; Xu W; Li M
Int Immunopharmacol; 2023 Mar; 116():109812. PubMed ID: 36746022
[TBL] [Abstract][Full Text] [Related]
20. Targeting Necroptosis as a Promising Therapy for Alzheimer's Disease.
Zhao W; Liu Y; Xu L; He Y; Cai Z; Yu J; Zhang W; Xing C; Zhuang C; Qu Z
ACS Chem Neurosci; 2022 Jun; 13(12):1697-1713. PubMed ID: 35607807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
